![]() | ![]() | ![]() | ![]() | ![]() | |||||||||||||
![]() | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
A Valentine's Day Gift Designed Just for Women:Thursday February 13, 12:37 pm ET Popularity of Zestra, The Botanical Oil That Enhances Female Sexual Pleasure, Grows Rapidly; Availability Increases While Alternatives Lack Desired Results, Or Are Not Yet Available - Positive Results from Zestra's Own Clinical Trial Boost Sales
NEW YORK, Feb. 13 /PRNewswire/ -- Sales of Zestra for Women(TM), the botanical feminine massage oil formulated to enhance female sexual pleasure and
arousal, have steadily grown since September and have surged in the days leading up to Valentine's Day.
* Availability of Zestra For Women has increased -- in addition to having
the ability to discreetly purchase Zestra online or by toll free
number, the Zestra Provider Network for the first time allows
physicians, including urologists, gynecologists, psychiatrists, sex
therapists and others, to recommend and provide this clinically proven
product;
* Journal of Sex & Marital Therapy article published on Zestra for Women
clinical trial -- the current issue of this peer-reviewed medical
journal includes a 12-page report on the successful results of a
randomized, placebo-controlled, double blind crossover design trial
that proved the efficacy and safety of Zestra for Women;
* Results on the use of Viagra(R) by women are not promising -- Pfizer
(NYSE: PFE - News) reported last November on results of female use
of Viagra in women with female sexual arousal disorder (FSAD). The
percentage of positive results was not much greater than in a group
using a placebo.
* Other promising alternatives are years away -- Products such as
Femprox, under development by NexMed Inc. (Nasdaq: NEXM - News),
have had successful early clinical trials but are
still years away from potential FDA approval.
"Unlike alternatives, Zestra for Women is a consumer product that is available now and can be discreetly purchased by women, without a prescription,
is safe and effective as proven in a clinical trial, and does not have the potential for significant adverse reactions, as many prescription
medications do," said Martin G. Crosby, a clinical research pharmacist, founder and CEO of QualiLife Pharmaceuticals, Inc., the developer of Zestra
for Women.
Zestra for Women is available from participating doctors, pharmacies and other healthcare providers and by calling toll free 1-877-4-ZESTRA (877-493-7872) or discreetly at the company's website: www.zestraforwomen.com. Zestra Laboratories, Inc., focuses on developing and commercializing meaningful consumer products for the sexual health marketplace. CORPORATE CONTACT: Martin G. Crosby, R.Ph. Chairman & Chief Science Officer Zestra Laboratories, Inc. 4055 Faber Place Drive, Suite 300 Charleston, SC 29405 843.402.0901 (phone) 843.402.0919 (fax) www.zestraforwomen.com
Source: Zestra Laboratories, Inc. |
|
![]() | |||||
| |||||